Skip to content

Effectiveness of topical natural oil blend to treat Primary dysmenorrhea

A randomized, double blind, placebo-controlled, crossover study to evaluate the effectiveness of topical application of Go-Go YIN oil blend on relieving the symptoms of Primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013438
Enrollment
64
Registered
2018-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary dysmenorrhea Health Condition 2: N944- Primary dysmenorrhea

Interventions

Intervention1: Go-Go YIN oil: Natural- plant extract based oil blend The subjects will be instructed to start applying the product 2 days prior to tentative start of the menstrual cycle and will conti

Sponsors

GODS OWN STORE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants must be single females, aged 18-20 years old with regular cycles lasting three to seven days. Subjects must have a negative pregnancy test. Pregnant patients or individual with history of pregnancy will be excluded from the study. 2. Subjects suffering from primary dysmenorrhea with a pain level >5 (severe pain) on a visual analogue scale and are not undergoing treatment for the pain. 3. The menstrual discomfort experienced should not be due to secondary dysmenorrhea and the Subjects should not be suffering from any systemic or gynaecologic disorders. 4. Participants should be willing to sign a written consent for participation in the study and undergo a baseline interview. 5. Participants must be willing to commit to medication dosing and assessment visits for evaluation. 6. Participants must be willing to refrain from taking analgesics from the outset of the study until second phase evaluation (if patient force to take allopathic medicine, subject will be dropped from the study). 7. Participants must agree that during the study they will refrain from taking any new herbal supplement and prescription or non-prescription medications without prior approval of the research team. 8. Participants must agree to take healthy diet and life style

Exclusion criteria

Exclusion criteria: 1. Participants with known or suspected secondary dysmenorrhea (major abdominal or pelvic surgery, endometriosis, pelvic inflammatory disease (PID), ovarian cysts, pathological vaginal secretion, chronic abdominal pain, inflammatory bowel disease, and irritable bowel syndrome). 2. Single or married subjects who are pregnant or have borne children. 3. Participants with a history of or current any kind of hormonal therapy during the last 6 months. 4. Participants with evidence or history of significant systemic or gynecological disorder. (People with hypothyroidism who are on adequate and stable thyroid replacement will not be excluded). 5. Participants weighing less than 50 kg and malnourished. 6. Patients reporting use of analgesics during the study period. 7. Participant with known allergies to the main components of the test product or placebo. 8. Any participant who is not able to give adequate informed consent.

Design outcomes

Primary

MeasureTime frame
1. reduction of menstrual cramps and 2. reduction in abdominal/pelvic pain within 30 minutes of the application of Go-Go Yin essential oil blend during the first three days of menstruation as compared to the placebo. 3. Reduction in the duration of menstruation and/or 4. Regulating excessive menstrual bleeding and improve pelvic health. Timepoint: Baseline Visit (Assessment Visit 1) Day 4 menstrual cycle 1 Assessment Visit 2 Day 4, menstrual cycle 2 Assessment Visit 3 Day 4, menstrual cycle 3

Secondary

MeasureTime frame
Adverse EventsTimepoint: Baseline Visit (Assessment Visit 1) Day 4 menstrual cycle 1 Assessment Visit 2 Day 4, menstrual cycle 2 Assessment Visit 3 Day 4, menstrual cycle 3

Countries

India

Contacts

Public ContactDr Anit Singh MD

Clinical Research Network India

anitsmd@gmail.com9866330090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026